Sternocleidomastoid Thickness in Sarcopenia

ConditionSarcopenia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNamik Kemal University

About this trial

In order to prevent sarcopenia in intensive care patients and to guide nutritional therapy, evaluation of muscle thickness with ultrasonography is a modern, simple and non-invasive procedure routinely performed by Anesthesiology and Reanimation specialists. Sarcopenia in intensive care patients has been demonstrated in many studies. It has been studied that routine examination of changes in rectus femoris muscle thickness by ultrasonography is a predictor of sarcopenia. However, the muscles in the neck region, such as the sternocleidomastoid muscle, which are easy to examine, have not been studied very well. There is no study in the literature with the sternocleidomastoid muscle. For this reason, we decided to examine the relationship of sternocleidomastoid muscle thickness with patient characteristics, treatments, feeding route and type, feeding time, length of stay in intensive care unit, as in routine measurements of rectus femoris muscle thickness by ultrasonography.

Eligibility criteria

Qualifiers

Patients who are expected to be followed up in the intensive care unit for at least 1 week

Patients over 18 years old

Disqualifiers

Patients under 18 years of age

Head-neck, femur trauma patients

Those with a diagnosis of primary neuromuscular disease

Those who have a condition that prevents imaging in the body parts where ultrasonography is planned

Trial design

Treatments tested in this trial

  • Muscle thickness measurement

Treatment groups

80 Participants
are divided into 1 treatment group

Sponsors and collaborators